Ads
related to: triple negative breast cancer- Ask Merck
Connect With a Merck Associate Now
or Schedule a Call.
- Adverse Reactions
Learn About Possible Adverse
Reactions and Safety Information.
- Dosing and Administration
Get Dosing Information for a
TNBC Treatment Option Here.
- Clinical Trial Results
Read Results From
an Official Clinical Trial.
- Safety Information
See Safety Information for
a TNBC Treatment Option.
- Official HCP Site
Learn About a Treatment Option for
Patients With TNBC.
- Ask Merck
Search results
Promising Combination Therapy for Triple Negative Breast Cancer Treatment: A Milestone Collaboration...
NewMediaWire via Yahoo Finance· 2 days agoFREMONT, CA - (NewMediaWire) - May 15, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a...
No Improvement in OS With Atezolizumab in Relapsing TNBC
Medscape· 2 days agoEarly relapsing disease has again shown the limitations of immunotherapy in triple-negative breast ...
Confused by new mammogram guidelines? Here’s what to know.
Anchorage Daily News· 5 days agoPreviously, the guidance from the U.S. Preventive Services Task Force was for women to make...
Exploring the prognostic significance of arm-level copy number alterations in triple-negative breast...
Nature· 4 days agoWhile focal SCNAs have been extensively studied, the impact of larger arm-level SCNAs remains poorly understood. Here, we investigated the association between arm-level SCNAs and overall survival ...
'I can do this.' Breast cancer patient encourages others on their journey
WZZM 13 Grand Rapids· 4 days agoJen VanEe says "there was no reason for me to get cancer." "I've never had any mentality outside of...
Cancer death rates are dropping, but not for everyone
Scripps News via AOL· 2 days agoBlack women are two times more likely than white women to be diagnosed highly aggressive triple-...
New breast cancer genes found in women of African ancestry, may improve risk assessment
Reuters via AOL· 4 days agoTwelve breast cancer genes identified in women of African ancestry in a large study published on...
Third Party Withdraws Appeal Related to Cantargia Patent
Digital Journal· 1 day agoThe main program, the antibody nadunolimab (CAN04), is being studied clinically primarily in combination with chemotherapy with a focus on pancreatic cancer, non-small cell lung cancer and & ...
Opinion: What you need to know about breast cancer screening guidelines
Stamford Advocate· 4 days agoYou may have seen the recent news about the breast cancer screening guidelines. It is good news for...
BioNTech (NASDAQ:BNTX) Coverage Initiated by Analysts at Evercore ISI
ETF DAILY NEWS· 3 days agoEvercore ISI assumed coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. TD Cowen boosted their price objective ...
